Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2003 | 2 |
2004 | 1 |
2005 | 2 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
Page 1
Prenatal screening for cystic fibrosis.
Clin Lab Med. 2003 Jun;23(2):503-30, x-xi. doi: 10.1016/s0272-2712(03)00033-7.
Clin Lab Med. 2003.
PMID: 12848456
Review.
An evaluation of BRCA1 and BRCA2 founder mutations penetrance estimates for breast cancer among Ashkenazi Jewish women.
McClain MR, Nathanson KL, Palomaki GE, Haddow JE.
McClain MR, et al.
Genet Med. 2005 Jan;7(1):34-9. doi: 10.1097/01.gim.0000151156.14983.08.
Genet Med. 2005.
PMID: 15654226
Item in Clipboard
Clinical sensitivity of prenatal screening for cystic fibrosis via CFTR carrier testing in a United States panethnic population.
Palomaki GE, FitzSimmons SC, Haddow JE.
Palomaki GE, et al.
Genet Med. 2004 Sep-Oct;6(5):405-14. doi: 10.1097/01.gim.0000139505.06194.39.
Genet Med. 2004.
PMID: 15371905
Free article.
Item in Clipboard
Adjusting the estimated proportion of breast cancer cases associated with BRCA1 and BRCA2 mutations: public health implications.
McClain MR, Palomaki GE, Nathanson KL, Haddow JE.
McClain MR, et al.
Genet Med. 2005 Jan;7(1):28-33. doi: 10.1097/01.gim.0000151155.36470.ff.
Genet Med. 2005.
PMID: 15654225
Item in Clipboard
Estimated analytic validity of HFE C282Y mutation testing in population screening: the potential value of confirmatory testing.
Palomaki GE, Haddow JE, Bradley LA, Richards CS, Stenzel TT, Grody WW.
Palomaki GE, et al.
Genet Med. 2003 Nov-Dec;5(6):440-3. doi: 10.1097/01.gim.0000096500.66084.85.
Genet Med. 2003.
PMID: 14614395
Item in Clipboard
Cite
Cite